Brief: Xvivo Q3 EBIT SEK 5.3 Million
Oct 24 (Reuters) - Xvivo Q3 EPS SEK 0.08. * Q3 adjusted EBIT SEK 14.4 million * Q3 net income SEK 2.3 million * Q3 sales SEK 146.6 million
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength